HRP20000733B1 - NOVI DERIVATI OKTAHIDRO-6,10-DIOKSO-6H-PIRIDAZINO [1,2-a] [1,2]DIAZEPIN-1-KARBOKSILNE KISELINE, POSTUPAK NJIHOVOG DOBIVANJA I UPOTREBA U DOBIVANJU TERAPEUTSKI AKTIVNIH SPOJEVA - Google Patents

NOVI DERIVATI OKTAHIDRO-6,10-DIOKSO-6H-PIRIDAZINO [1,2-a] [1,2]DIAZEPIN-1-KARBOKSILNE KISELINE, POSTUPAK NJIHOVOG DOBIVANJA I UPOTREBA U DOBIVANJU TERAPEUTSKI AKTIVNIH SPOJEVA

Info

Publication number
HRP20000733B1
HRP20000733B1 HR20000733A HRP20000733A HRP20000733B1 HR P20000733 B1 HRP20000733 B1 HR P20000733B1 HR 20000733 A HR20000733 A HR 20000733A HR P20000733 A HRP20000733 A HR P20000733A HR P20000733 B1 HRP20000733 B1 HR P20000733B1
Authority
HR
Croatia
Prior art keywords
pyridazino
diazepin
dioxo
preparation
carboxylic acid
Prior art date
Application number
HR20000733A
Other languages
English (en)
Inventor
Colladant Colette
Crocq Veronique
Patrick Larkin John
Roussel Patrick
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HRP20000733A2 publication Critical patent/HRP20000733A2/hr
Publication of HRP20000733B1 publication Critical patent/HRP20000733B1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Spojevi formule (I): u obliku (9S, 1R) + (9S, 1S) smjese, naznačeni time, da R predstavlja atom vodika ili radikal alkila ili aralkila koji sadrži do 18 ugljikovih atoma, gdje funkcionalna amino skupina može biti slobodna ili zaštićena. Patent sadrži još 14 patentnih zahtjeva.
HR20000733A 1998-04-27 2000-10-27 NOVI DERIVATI OKTAHIDRO-6,10-DIOKSO-6H-PIRIDAZINO [1,2-a] [1,2]DIAZEPIN-1-KARBOKSILNE KISELINE, POSTUPAK NJIHOVOG DOBIVANJA I UPOTREBA U DOBIVANJU TERAPEUTSKI AKTIVNIH SPOJEVA HRP20000733B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9805243A FR2777889B1 (fr) 1998-04-27 1998-04-27 Nouveaux derives de l'acide octahydro-6,10-dioxo-6h- pyridazino[1,2-a][1,2]diazepine-1-carboxylique, leur procede de preparation et leur application a la preparation de composes therapeutiquement actifs
PCT/FR1999/000981 WO1999055724A1 (fr) 1998-04-27 1999-04-26 NOUVEAUX DERIVES DE L'ACIDE OCTAHYDRO-6,10-DIOXO-6H-PYRIDAZINO[1,2-a] [1,2] DIAZEPINE-1-CARBOXYLIQUE, LEUR PROCEDE DE PREPARATION ET LEUR APPLICATION A LA PREPARATION DE COMPOSES THERAPEUTIQUEMENT ACTIFS

Publications (2)

Publication Number Publication Date
HRP20000733A2 HRP20000733A2 (en) 2001-02-28
HRP20000733B1 true HRP20000733B1 (hr) 2009-06-30

Family

ID=9525705

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000733A HRP20000733B1 (hr) 1998-04-27 2000-10-27 NOVI DERIVATI OKTAHIDRO-6,10-DIOKSO-6H-PIRIDAZINO [1,2-a] [1,2]DIAZEPIN-1-KARBOKSILNE KISELINE, POSTUPAK NJIHOVOG DOBIVANJA I UPOTREBA U DOBIVANJU TERAPEUTSKI AKTIVNIH SPOJEVA

Country Status (38)

Country Link
US (3) US6548664B1 (hr)
EP (1) EP1073673B1 (hr)
JP (2) JP4332298B2 (hr)
KR (1) KR100561582B1 (hr)
CN (1) CN1167711C (hr)
AP (1) AP1518A (hr)
AR (1) AR016466A1 (hr)
AU (1) AU755286B2 (hr)
BG (1) BG65282B1 (hr)
BR (1) BR9910020A (hr)
CA (1) CA2330492C (hr)
CU (1) CU23155A3 (hr)
CY (1) CY1107599T1 (hr)
DE (1) DE69934790T2 (hr)
DK (1) DK1073673T3 (hr)
EA (1) EA003280B1 (hr)
EE (1) EE04682B1 (hr)
ES (1) ES2279617T3 (hr)
FR (1) FR2777889B1 (hr)
GE (1) GEP20033119B (hr)
HK (1) HK1039131A1 (hr)
HR (1) HRP20000733B1 (hr)
HU (1) HU230060B1 (hr)
ID (1) ID26292A (hr)
IL (3) IL139102A0 (hr)
ME (2) MEP40808A (hr)
NO (1) NO328864B1 (hr)
NZ (1) NZ507618A (hr)
PL (1) PL203762B1 (hr)
PT (1) PT1073673E (hr)
RS (1) RS50423B (hr)
SI (1) SI1073673T1 (hr)
SK (1) SK288050B6 (hr)
TR (1) TR200003142T2 (hr)
TW (1) TWI249537B (hr)
UA (1) UA71913C2 (hr)
WO (1) WO1999055724A1 (hr)
ZA (1) ZA200006081B (hr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177565B1 (en) 1998-08-19 2001-01-23 Vertex Pharmaceuticals Inc. Process for synthesizing piperazic acid
US6201118B1 (en) 1998-08-19 2001-03-13 Vertex Pharmaceuticals Inc. Process for forming an N-acylated, N,N-containing bicyclic ring from piperazic acid or an ester thereof especially useful as an intermediate in the manufacture of a caspase inhibitor
FR2853901B1 (fr) * 2003-04-16 2005-06-17 Isochem Sa Procede de preparation de derives de l'acide hexahydropyridazine-3-carboxylique
WO2005028449A1 (en) * 2003-06-26 2005-03-31 Honeywell Specialty Chemicals Seelze Gmbh Improved process for the manufacture of 1,2-disubstituted hexahydropyridazine-3-carboxylic acids and esters thereof
CN100404516C (zh) * 2004-02-13 2008-07-23 大连绿源药业有限责任公司 六氢哒嗪三羧酸酯的制备方法
WO2005122682A2 (en) 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited Process for the preparation of esters of piperazic acid
WO2012049646A1 (en) 2010-10-12 2012-04-19 Ranbaxy Laboratories Limited Process for the preparation of an intermediate of cilazapril
JP7102199B2 (ja) 2018-04-11 2022-07-19 キヤノン株式会社 駆動装置、像ぶれ補正装置及び撮像装置

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512924A (en) * 1982-05-12 1985-04-23 Hoffmann-La Roche Inc. Pyridazo[1,2-a][1,2]diazepines
WO1993023403A1 (en) * 1992-05-15 1993-11-25 Merrell Dow Pharmaceuticals Inc. NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
US5723602A (en) * 1992-05-18 1998-03-03 E. R. Squibb & Sons, Inc. Dual action inhibitors containing a pyridazinodiazepine or pyrazolodiazepine lactam ring

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5552400A (en) * 1994-06-08 1996-09-03 Sterling Winthrop Inc. Fused-bicyclic lactams as interleukin-1β converting enzyme inhibitors
US5756466A (en) * 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US6177565B1 (en) * 1998-08-19 2001-01-23 Vertex Pharmaceuticals Inc. Process for synthesizing piperazic acid
US6201118B1 (en) * 1998-08-19 2001-03-13 Vertex Pharmaceuticals Inc. Process for forming an N-acylated, N,N-containing bicyclic ring from piperazic acid or an ester thereof especially useful as an intermediate in the manufacture of a caspase inhibitor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4512924A (en) * 1982-05-12 1985-04-23 Hoffmann-La Roche Inc. Pyridazo[1,2-a][1,2]diazepines
WO1993023403A1 (en) * 1992-05-15 1993-11-25 Merrell Dow Pharmaceuticals Inc. NOVEL MERCAPTOACETYLAMIDO PYRIDAZO[1,2]PYRIDAZINE, PYRAZOLO[1,2]PYRIDAZINE, PYRIDAZO[1,2-a][1,2]DIAZEPINE AND PYRAZOLO[1,2-a][1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
US5723602A (en) * 1992-05-18 1998-03-03 E. R. Squibb & Sons, Inc. Dual action inhibitors containing a pyridazinodiazepine or pyrazolodiazepine lactam ring

Also Published As

Publication number Publication date
CA2330492C (fr) 2012-03-13
EE04682B1 (et) 2006-08-15
HU230060B1 (hu) 2015-06-29
ID26292A (id) 2000-12-14
PL203762B1 (pl) 2009-11-30
WO1999055724A1 (fr) 1999-11-04
EE200000619A (et) 2002-06-17
GEP20033119B (en) 2003-11-25
SK288050B6 (sk) 2013-03-01
JP2009155343A (ja) 2009-07-16
JP4332298B2 (ja) 2009-09-16
HUP0102447A3 (en) 2003-05-28
CA2330492A1 (fr) 1999-11-04
CN1306539A (zh) 2001-08-01
TWI249537B (en) 2006-02-21
AU755286B2 (en) 2002-12-05
HRP20000733A2 (en) 2001-02-28
CY1107599T1 (el) 2013-03-13
CU23155A3 (es) 2006-07-18
JP2002513030A (ja) 2002-05-08
EP1073673A1 (fr) 2001-02-07
NO20005391D0 (no) 2000-10-26
RS50423B (sr) 2009-12-31
EP1073673B1 (fr) 2007-01-10
JP5101558B2 (ja) 2012-12-19
TR200003142T2 (tr) 2001-03-21
IL139102A0 (en) 2001-11-25
EA003280B1 (ru) 2003-04-24
BG104891A (en) 2001-10-31
HUP0102447A2 (hu) 2001-11-28
ES2279617T3 (es) 2007-08-16
PL343720A1 (en) 2001-09-10
KR20010043033A (ko) 2001-05-25
CN1167711C (zh) 2004-09-22
US6548664B1 (en) 2003-04-15
DE69934790T2 (de) 2007-10-31
KR100561582B1 (ko) 2006-03-20
US6570012B2 (en) 2003-05-27
FR2777889A1 (fr) 1999-10-29
DK1073673T3 (da) 2007-05-07
IL190120A (en) 2011-10-31
AP1518A (en) 2005-12-12
US20020128473A1 (en) 2002-09-12
MEP40808A (en) 2011-02-10
HK1039131A1 (en) 2002-04-12
BR9910020A (pt) 2001-01-09
AU3427499A (en) 1999-11-16
AR016466A1 (es) 2001-07-04
NO328864B1 (no) 2010-05-31
SI1073673T1 (sl) 2007-04-30
ME00300B (me) 2011-05-10
BG65282B1 (bg) 2007-11-30
YU65800A (sh) 2003-01-31
AP2000001973A0 (en) 2000-12-31
NO20005391L (no) 2000-12-19
IL190120A0 (en) 2008-08-07
FR2777889B1 (fr) 2004-07-09
PT1073673E (pt) 2007-03-30
DE69934790D1 (de) 2007-02-22
IL139102A (en) 2008-06-05
SK16002000A3 (sk) 2001-09-11
UA71913C2 (uk) 2005-01-17
EA200001107A1 (ru) 2001-04-23
NZ507618A (en) 2003-07-25
US20030130269A1 (en) 2003-07-10
ZA200006081B (en) 2001-10-29

Similar Documents

Publication Publication Date Title
CA2304713A1 (en) Biphenyl-5-alkanoic acid derivatives and use thereof
HUP0100394A2 (hu) 2-es Helyzetben fenil-szubsztituenst hordozó imidazo-triazinon-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0400694A2 (hu) A rotamáz enzim aktivitásának kis molekulájú inhibitorai, valamint ezeket a vegyületeket tartalmazó gyógyászati készítmények
CZ15795A3 (en) Derivatives of hydroxamic acid, process of their preparation, their use for preparing pharmaceutical preparations and pharmaceutical compositions containing thereof
NO308792B1 (no) Derivater av valproinsyre og 2-valproensyreamider, farmasøytisk sammensetning derav og deres anvendelse for fremstilling av et farmasøytisk preparat
HUP0302962A2 (hu) Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása
BRPI0315188B8 (pt) composto e composição farmacêutica
RS49906B (sr) Benzociklohepteni, postupak za njihovo dobijanje, farmaceutski preparati koji ove sadrže kao i njihova primena za izradu lekova
AU528275B2 (en) Imidazole derivatives
ES8200645A1 (es) Un procedimiento para la preparacion de un muramildipeptido.
HUP0100865A2 (hu) Meta-azaciklusos csoporttal N-szubsztituált amino-benzoesav-vegyületek és származékaik mint integrin antagonista hatóanyagok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
IE872588L (en) Compounds
HRP20000733B1 (hr) NOVI DERIVATI OKTAHIDRO-6,10-DIOKSO-6H-PIRIDAZINO [1,2-a] [1,2]DIAZEPIN-1-KARBOKSILNE KISELINE, POSTUPAK NJIHOVOG DOBIVANJA I UPOTREBA U DOBIVANJU TERAPEUTSKI AKTIVNIH SPOJEVA
HUP0003577A2 (hu) Tetrahidro-gamma-karbolinok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
ES2000456A6 (es) Procedimiento para preparar deirvados de acido eicosatriinoico-5,8,11 y utilizacion de estos en composiciones farmaceuticas y cosmeticas.
ES8404360A1 (es) Un procedimiento para preparar compuestos de cefem.
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
AU558261B2 (en) Dialkylaminoalkyoxybenzylalcohol derivatives
ZA9810834B (en) Pyrrole compounds a process for their preparation and pharmaceutical compositions containing them
JPS6413083A (en) Streptonigrin derivative and medicinal composition
AU4953997A (en) New histidine derivatives, preparation process, and their use as free antiradical agents
SE9701912D0 (sv) Pharmaceutical composition and use thereof
DK0865422T3 (da) Anvendelse af aminoalkoholderivater som lægemidler, hidtil ukendte derivater og fremgangsmåde til fremstilling deraf

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PPPP Transfer of rights

Owner name: AVENTIS PHARMA S.A., FR

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20170320

Year of fee payment: 19

PBON Lapse due to non-payment of renewal fee

Effective date: 20180426